Dynamics of β-Amyloid Reductions in Brain, Cerebrospinal Fluid, and Plasma of β-Amyloid Precursor Protein Transgenic Mice Treated with a γ-Secretase Inhibitor
Donna M. Barten(Vertex Pharmaceuticals (United States)), Valerie Guss(NeuroGenetic Pharmaceuticals (United States)), Jason A. Corsa(Johnson & Johnson (United States)), Alice Loo(Intra Cellular Therapies (United States)), Steven Hansel(Johnson & Johnson (United States)), Ming Zheng(Johnson & Johnson (United States)), B. Muñoz(NeuroGenetic Pharmaceuticals (United States)), K. Srinivasan(Vertex Pharmaceuticals (United States)), Binghe Wang(Pfizer (United States)), Barbara Robertson(Vertex Pharmaceuticals (United States)), Craig Polson(Vertex Pharmaceuticals (United States)), Jue Wang(Pfizer (United States)), Susan B. Roberts(Bristol-Myers Squibb (United States)), Joseph P. Hendrick(Vertex Pharmaceuticals (United States)), Jeffrey J. Anderson(Pfizer (United States)), James Loy(Bristol-Myers Squibb (United States)), Ross M. Denton(Merck & Co., Inc., Rahway, NJ, USA (United States)), Todd A. Verdoorn(NeuroGenetic Pharmaceuticals (United States)), David W. Smith(Pfizer (United States)), Kevin M. Felsenstein(Vertex Pharmaceuticals (United States))
Cited by 159
Abstract
Related Papers
No related papers found
Powered by citation graph analysis